NPI Details
Mark Scarupa, M.D. is an allergy immunology in Wheaton, MD with 26 years of experience. The provider is an allergist-immunologist is trained in evaluation, physical and laboratory diagnosis, and management of disorders involving the immune system. Selected examples of such conditions include asthma, anaphylaxis, rhinitis, eczema, and adverse reactions to drugs, foods, and insect stings as well as immune deficiency diseases (both acquired and congenital), defects in host defense, and problems related to autoimmune disease, organ transplantation, or malignancies of the immune system. Mark Scarupa, M.D. NPI is 1659303774. The provider is registered as an individual entity type.
The NPPES NPI record indicates the provider is a male.
Education
Medical School: UNIVERSITY OF MINNESOTA MEDICAL SCHOOL
Graduation Year:1999
The provider's business location address is:
11002 VEIRS MILL RD
414
WHEATON, MD
ZIP 20902-574
Phone: (301) 962-1605
The NPI 1659303774 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.
The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.
- Injection, omalizumab, 5 mg (HCPCS:J2357)
- Injection, immune globulin (bivigam), 500 mg (HCPCS:J1556)
- Test for allergy using allergenic extract (HCPCS:95004)
- Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg (HCPCS:J1568)
- Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
- Test for allergy using skin patch (HCPCS:95044)
- Professional service for preparation and provision of 1 or more antigens (HCPCS:95165)
- Professional service for multiple injections of allergen (HCPCS:95117)
- Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
- Administration and interpretation of patient-focused health risk assessment (HCPCS:96160)
- Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
- Test for allergy using combination of methods with drug or biological (HCPCS:95018)
- Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
- Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
- Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
- Flow cytometry technique for dna or cell analysis, 16 or more markers (HCPCS:88189)
- Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)
- Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
- New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
- Injection of drug or substance under skin or into muscle (HCPCS:96372)
- Infusion into a vein for hydration, each additional hour (HCPCS:96361)
- Insertion of needle into vein for collection of blood sample (HCPCS:36415)
- 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0004)
- Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
- Test to measure expiratory airflow and volume (HCPCS:94010)
- Influenza vaccine split virus, preservative free (HCPCS:90662)
- New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
- Administration of influenza virus vaccine (HCPCS:G0008)
- Screening test for detection of severe acute respiratory syndrome coronavirus 2 (covid-19) neutralizing antibody (HCPCS:86408)
- Fee covid-19 vac 13 res (HCPCS:0124A)
- Evaluation of use of breathing device (HCPCS:94664)
The enumeration date for this NPI number is 7/7/2006 and was last updated on 10/23/2007.
Taxonomy Codes
The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:
| No. |
Taxonomy Code |
Taxonomy Clasification |
Taxonomy Specialization |
License Number |
License State |
Primary |
| 1 | 207K00000X | Allergy & Immunology | | D61301 | MARYLAND | Yes |
Other Identifiers
The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.
| No. |
Other Provider Identifier |
Other Provider Identifier Type |
Other Provider Identifier State |
Other Provider Identifier Issuer |
| 1 | 695044 | OTHER | MARYLAND | NCPPO |
| 2 | 02-00863 | OTHER | MARYLAND | UNITED HEALTHCARE |
| 3 | 247132 | OTHER | MARYLAND | KAISER |
| 4 | I20696 | MEDICARE UPIN | MARYLAND | |
| 5 | 015216I81 | MEDICARE PIN | MARYLAND | |
| 6 | 2133588 | OTHER | MARYLAND | MAMSI |
| 7 | C4540007 | OTHER | MARYLAND | CAREFIRST NCA |
| 8 | 7828646 | OTHER | MARYLAND | AETNA |
